Isolation and characterization of a cisplatin-resistant strain of Schizosaccharomyces pombe

Paola Perego, Gretchen Jimenez, Stephen B. Howell

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

A cis-diamminedichloroplatinum [DDP (cisplatin)]-resistant population of Schizosaccharomyces pombe was developed through chronic exposure of the 972 h strain to increasing concentrations of the drug. The resulting cells, designated wtr2, were 5.25-fold resistant to DDP, and resistance was retained by clone isolated from this population in the absence of drug for >5 months. After backcrossing and isolation of a single clone, random spore analysis gave a segregation ratio close to 1:1 for DDP resistance and sensitivity. Tetrad analysis confirmed a mendelian 2:2 segregation, suggesting that a single nuclear gene was responsible for the DDP-resistant phenotype. Stable diploids obtained from the mating of a resistant spore carrying the ade6-216 marker with the mei2-102-ade6-210 meiosis-deficient mutant remained resistant, indicating that the resistant phenotype was expressed dominantly. There was no difference between the accumulation of the DDP analog [3H]dichloro(ethylenediamine)-platinum(II) into whole cells derived from the sensitive and the resistant spores obtained from the last backcross. The resistant clones from a single tetrad did not have an increased level of glutathione and were collaterally sensitive to cadmium and arsenite. We conclude that in S. pombe, a stable and dominant DDP-resistant phenotype can be mediated by a single allele, that the phenotype is not accompanied by cross-resistance to cadmium or arsenite, and that the mechanism is not associated with a significant alteration in glutathione level or DDP uptake.

Original languageEnglish
Pages (from-to)1080-1086
Number of pages7
JournalMolecular Pharmacology
Volume50
Issue number5
Publication statusPublished - Nov 1996

Fingerprint

Schizosaccharomyces
Cisplatin
Spores
Phenotype
ethylenediamine
Clone Cells
Cadmium
Glutathione
Inbreeding
Meiosis
Platinum
Diploidy
Pharmaceutical Preparations
Population
Alleles
Genes
arsenite

ASJC Scopus subject areas

  • Pharmacology

Cite this

Isolation and characterization of a cisplatin-resistant strain of Schizosaccharomyces pombe. / Perego, Paola; Jimenez, Gretchen; Howell, Stephen B.

In: Molecular Pharmacology, Vol. 50, No. 5, 11.1996, p. 1080-1086.

Research output: Contribution to journalArticle

Perego, Paola ; Jimenez, Gretchen ; Howell, Stephen B. / Isolation and characterization of a cisplatin-resistant strain of Schizosaccharomyces pombe. In: Molecular Pharmacology. 1996 ; Vol. 50, No. 5. pp. 1080-1086.
@article{887de7e176c74f77b0d1f22f064fd040,
title = "Isolation and characterization of a cisplatin-resistant strain of Schizosaccharomyces pombe",
abstract = "A cis-diamminedichloroplatinum [DDP (cisplatin)]-resistant population of Schizosaccharomyces pombe was developed through chronic exposure of the 972 h strain to increasing concentrations of the drug. The resulting cells, designated wtr2, were 5.25-fold resistant to DDP, and resistance was retained by clone isolated from this population in the absence of drug for >5 months. After backcrossing and isolation of a single clone, random spore analysis gave a segregation ratio close to 1:1 for DDP resistance and sensitivity. Tetrad analysis confirmed a mendelian 2:2 segregation, suggesting that a single nuclear gene was responsible for the DDP-resistant phenotype. Stable diploids obtained from the mating of a resistant spore carrying the ade6-216 marker with the mei2-102-ade6-210 meiosis-deficient mutant remained resistant, indicating that the resistant phenotype was expressed dominantly. There was no difference between the accumulation of the DDP analog [3H]dichloro(ethylenediamine)-platinum(II) into whole cells derived from the sensitive and the resistant spores obtained from the last backcross. The resistant clones from a single tetrad did not have an increased level of glutathione and were collaterally sensitive to cadmium and arsenite. We conclude that in S. pombe, a stable and dominant DDP-resistant phenotype can be mediated by a single allele, that the phenotype is not accompanied by cross-resistance to cadmium or arsenite, and that the mechanism is not associated with a significant alteration in glutathione level or DDP uptake.",
author = "Paola Perego and Gretchen Jimenez and Howell, {Stephen B.}",
year = "1996",
month = "11",
language = "English",
volume = "50",
pages = "1080--1086",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "5",

}

TY - JOUR

T1 - Isolation and characterization of a cisplatin-resistant strain of Schizosaccharomyces pombe

AU - Perego, Paola

AU - Jimenez, Gretchen

AU - Howell, Stephen B.

PY - 1996/11

Y1 - 1996/11

N2 - A cis-diamminedichloroplatinum [DDP (cisplatin)]-resistant population of Schizosaccharomyces pombe was developed through chronic exposure of the 972 h strain to increasing concentrations of the drug. The resulting cells, designated wtr2, were 5.25-fold resistant to DDP, and resistance was retained by clone isolated from this population in the absence of drug for >5 months. After backcrossing and isolation of a single clone, random spore analysis gave a segregation ratio close to 1:1 for DDP resistance and sensitivity. Tetrad analysis confirmed a mendelian 2:2 segregation, suggesting that a single nuclear gene was responsible for the DDP-resistant phenotype. Stable diploids obtained from the mating of a resistant spore carrying the ade6-216 marker with the mei2-102-ade6-210 meiosis-deficient mutant remained resistant, indicating that the resistant phenotype was expressed dominantly. There was no difference between the accumulation of the DDP analog [3H]dichloro(ethylenediamine)-platinum(II) into whole cells derived from the sensitive and the resistant spores obtained from the last backcross. The resistant clones from a single tetrad did not have an increased level of glutathione and were collaterally sensitive to cadmium and arsenite. We conclude that in S. pombe, a stable and dominant DDP-resistant phenotype can be mediated by a single allele, that the phenotype is not accompanied by cross-resistance to cadmium or arsenite, and that the mechanism is not associated with a significant alteration in glutathione level or DDP uptake.

AB - A cis-diamminedichloroplatinum [DDP (cisplatin)]-resistant population of Schizosaccharomyces pombe was developed through chronic exposure of the 972 h strain to increasing concentrations of the drug. The resulting cells, designated wtr2, were 5.25-fold resistant to DDP, and resistance was retained by clone isolated from this population in the absence of drug for >5 months. After backcrossing and isolation of a single clone, random spore analysis gave a segregation ratio close to 1:1 for DDP resistance and sensitivity. Tetrad analysis confirmed a mendelian 2:2 segregation, suggesting that a single nuclear gene was responsible for the DDP-resistant phenotype. Stable diploids obtained from the mating of a resistant spore carrying the ade6-216 marker with the mei2-102-ade6-210 meiosis-deficient mutant remained resistant, indicating that the resistant phenotype was expressed dominantly. There was no difference between the accumulation of the DDP analog [3H]dichloro(ethylenediamine)-platinum(II) into whole cells derived from the sensitive and the resistant spores obtained from the last backcross. The resistant clones from a single tetrad did not have an increased level of glutathione and were collaterally sensitive to cadmium and arsenite. We conclude that in S. pombe, a stable and dominant DDP-resistant phenotype can be mediated by a single allele, that the phenotype is not accompanied by cross-resistance to cadmium or arsenite, and that the mechanism is not associated with a significant alteration in glutathione level or DDP uptake.

UR - http://www.scopus.com/inward/record.url?scp=0029847405&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029847405&partnerID=8YFLogxK

M3 - Article

VL - 50

SP - 1080

EP - 1086

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 5

ER -